Welcome to LookChem.com Sign In|Join Free

CAS

  • or
p-Hydroxy-cinnamic acid, also known as 4-coumaric acid, is a hydroxy derivative of cinnamic acid with antioxidant properties. It is a major component of lignocellulose and has a role as a plant metabolite. This light yellow to beige crystalline powder has an aromatic smell and is soluble in various organic solvents such as methanol, ethanol, and DMSO. It is derived from synthesis and is known for its potential health benefits, including reducing the risk of cancer by decreasing the formation of carcinogenic nitrosamines.

7400-08-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 7400-08-0 Structure
  • Basic information

    1. Product Name: p-Hydroxy-cinnamic acid
    2. Synonyms: 4-hydroxylcinnamic acid;Alkaline ceramidase;Anti-PHCA antibody produced in rabbit;ACER3;Alkaline CDase 3;Alkaline ceramidase 3;Alkaline dihydroceramidase SB89;Alkaline phytoceramidase
    3. CAS NO:7400-08-0
    4. Molecular Formula: C9H8O3
    5. Molecular Weight: 164.16
    6. EINECS: 231-000-0
    7. Product Categories: Cinnamic acid
    8. Mol File: 7400-08-0.mol
  • Chemical Properties

    1. Melting Point: 214 °C (dec.)(lit.)
    2. Boiling Point: 251.61°C (rough estimate)
    3. Flash Point: 177.284 °C
    4. Appearance: Light yellow to beige crystalline powder
    5. Density: 1.2132 (rough estimate)
    6. Vapor Pressure: 7.19E-05mmHg at 25°C
    7. Refractive Index: 1.5380 (estimate)
    8. Storage Temp.: -20°C
    9. Solubility: Acetone (Slightly), Chloroform (Slightly), Methanol (Slightly)
    10. PKA: 4.65±0.10(Predicted)
    11. Stability: Light Sensitive
    12. CAS DataBase Reference: p-Hydroxy-cinnamic acid(CAS DataBase Reference)
    13. NIST Chemistry Reference: p-Hydroxy-cinnamic acid(7400-08-0)
    14. EPA Substance Registry System: p-Hydroxy-cinnamic acid(7400-08-0)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 36/37/38
    3. Safety Statements: 26-36-36/37/39-22
    4. WGK Germany: 2
    5. RTECS: GD9095000
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 7400-08-0(Hazardous Substances Data)

7400-08-0 Usage

Uses

1. Pharmaceutical Industry:
p-Hydroxy-cinnamic acid is used as an intermediate in the pharmaceutical industry for the production of various compounds. It can react with dimethyl sulfate to produce p-anisaldehyde, which is used in the synthesis of pharmaceuticals and fragrances. Additionally, it can react with acetaldehyde to produce p-hydroxycinnamaldehyde, which can be further oxidized to produce cinnamic acid. This acid can be directly oxidized to produce 4-Hydroxybenzoic acid, a compound with potential applications in the pharmaceutical industry, or reduced to produce 4-Hydroxybenzyl alcohol, another useful intermediate.
2. Perfume Industry:
In the perfume industry, p-Hydroxy-cinnamic acid serves as an intermediate for the synthesis of various fragrance compounds. The reaction with dimethyl sulfate to produce p-anisaldehyde is particularly important, as p-anisaldehyde is a key component in the creation of many perfumes.
3. Antioxidant Applications:
Due to its antioxidant properties, p-Hydroxy-cinnamic acid may be used in the development of antioxidant products, which can help protect cells from damage caused by free radicals. This application can be relevant in various industries, including the food and beverage industry, where antioxidants are used to extend the shelf life of products and maintain their quality.
4. Agricultural Applications:
A recent study suggests that p-Hydroxy-cinnamic acid may act as a chemical castrator in bees by altering the expression of genes required for ovary development. p-Hydroxy-cinnamic acid is common in pollen, a major constituent of the worker bee diet, but it is not found in queen bees' royal jelly. This information could be useful in the agricultural industry for managing bee populations and improving crop pollination.

Hazard

Moderately toxic.

Safety Profile

Moderarely toxic by intraperitoneal route. Experimental reproductive effects. When heated to decomposition it emits acrid smoke and fumes. See also COUMARIN

Check Digit Verification of cas no

The CAS Registry Mumber 7400-08-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,4,0 and 0 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 7400-08:
(6*7)+(5*4)+(4*0)+(3*0)+(2*0)+(1*8)=70
70 % 10 = 0
So 7400-08-0 is a valid CAS Registry Number.
InChI:InChI=1/C9H8O3/c1-6(9(11)12)7-2-4-8(10)5-3-7/h2-5,10H,1H2,(H,11,12)

7400-08-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-coumaric acid

1.2 Other means of identification

Product number -
Other names p-Hydroxy-cinnamic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:7400-08-0 SDS

7400-08-0Synthetic route

malonic acid
141-82-2

malonic acid

4-hydroxy-benzaldehyde
123-08-0

4-hydroxy-benzaldehyde

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

Conditions
ConditionsYield
With piperidine; pyridine for 1h; Knoevenagel-Doebner-Stobbe Reaction; Reflux;98%
With ammonium acetate for 0.05h; Irradiation;97%
With aluminum oxide; lithium chloride for 0.0833333h; Doebner condensation; microwave irradiation;97%
(E)-4-iodocinnamic acid
113641-76-2

(E)-4-iodocinnamic acid

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

Conditions
ConditionsYield
With copper(I) oxide; 1-D-O-Methyl-chiro-inositol; sodium hydroxide In water at 100℃; for 6h;88%
5-O-(E)-p-coumaroylquinic acid ethyl ester
1443678-33-8

5-O-(E)-p-coumaroylquinic acid ethyl ester

A

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

B

D-(-)-quinic acid
77-95-2

D-(-)-quinic acid

Conditions
ConditionsYield
With sulfuric acid; water In 1,4-dioxane at 90℃; for 3h;A n/a
B 2.5 mg
2'-O-acetyl-3-O-(E)-p-coumaroylsucrose

2'-O-acetyl-3-O-(E)-p-coumaroylsucrose

A

D-Fructose
57-48-7

D-Fructose

B

D-glucose
50-99-7

D-glucose

C

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

Conditions
ConditionsYield
With sulfuric acid; water In 1,4-dioxane at 90℃; for 3h;
3',6'-di-O-acetyl-3-O-(E)-p-coumaroylsucrose

3',6'-di-O-acetyl-3-O-(E)-p-coumaroylsucrose

A

D-Fructose
57-48-7

D-Fructose

B

D-glucose
50-99-7

D-glucose

C

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

Conditions
ConditionsYield
With sulfuric acid; water In 1,4-dioxane at 90℃; for 3h;
4,2',3',6'-tetra-O-acetyl-3-O-(E)-p-coumaroylsucrose
1446205-86-2

4,2',3',6'-tetra-O-acetyl-3-O-(E)-p-coumaroylsucrose

A

D-Fructose
57-48-7

D-Fructose

B

D-glucose
50-99-7

D-glucose

C

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

Conditions
ConditionsYield
With sulfuric acid; water In 1,4-dioxane at 90℃; for 3h;
1,2',3',4',6'-penta-O-acetyl-3-O-(E)-p-coumaroylsucrose
1392307-46-8

1,2',3',4',6'-penta-O-acetyl-3-O-(E)-p-coumaroylsucrose

A

D-Fructose
57-48-7

D-Fructose

B

D-glucose
50-99-7

D-glucose

C

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

Conditions
ConditionsYield
With sulfuric acid; water In 1,4-dioxane at 90℃; for 3h;
para-coumaric acid
7400-08-0

para-coumaric acid

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

Conditions
ConditionsYield
With iodine In d(4)-methanol at 50℃; for 0.166667h; Time; Green chemistry;
4-Iodophenol
540-38-5

4-Iodophenol

acrylic acid
79-10-7

acrylic acid

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

Conditions
ConditionsYield
With palladium diacetate; potassium carbonate In water at 80℃; for 2h;94%
With potassium carbonate In 1,4-dioxane; water at 80℃; for 12h; Inert atmosphere;93%
With tetrakis(triphenylphosphine) palladium(0); lithium chloride; potassium hydroxide In water at 85℃; for 3h; Heck Reaction;95 %Chromat.
L-tyrosine
60-18-4

L-tyrosine

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

Conditions
ConditionsYield
Einw. von Bacillus proteus vulgaris in Ringerscher Loesung;
With 1,3-bis[tris(hydroxymethyl)methylamino]-propane; Arabidopsis thaliana phenylalanine ammonia lyase 1 In water at 37℃; pH=8.4; Enzyme kinetics; Further Variations:; Reagents;
free cell extract of Rhodotorula rubra (ATCC 889) In Tris-HCl buffer pH=8.5; Kinetics; Enzymatic reaction;
kaempferol 3-O-{[(6-O-E-p-coumaroyl)-β-D-glucopyranosyl(1→2)]-α-L-rhamnopyranosyl(1→6)}-β-D-galactopyranoside-7-O-α-L-rhamnopyranoside

kaempferol 3-O-{[(6-O-E-p-coumaroyl)-β-D-glucopyranosyl(1→2)]-α-L-rhamnopyranosyl(1→6)}-β-D-galactopyranoside-7-O-α-L-rhamnopyranoside

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

Conditions
ConditionsYield
With sodium hydroxide; ascorbic acid at 20℃; for 2h; Darkness;
quercetin 3-O-[(6-O-E-p-coumaroyl)-β-D-glucopyranosyl(1→2)]-β-D-galactopyranoside-7-O-(2-O-E-caffeoyl)-β-D-glucuropyranoside

quercetin 3-O-[(6-O-E-p-coumaroyl)-β-D-glucopyranosyl(1→2)]-β-D-galactopyranoside-7-O-(2-O-E-caffeoyl)-β-D-glucuropyranoside

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

Conditions
ConditionsYield
With sodium hydroxide; ascorbic acid at 20℃; for 2h; Darkness;
quercetin 3-O-[(6-O-E-p-coumaroyl)-β-D-glucopyranosyl-(1→2)]-β-D-galactopyranoside-7-O-β-D-glucuropyranoside

quercetin 3-O-[(6-O-E-p-coumaroyl)-β-D-glucopyranosyl-(1→2)]-β-D-galactopyranoside-7-O-β-D-glucuropyranoside

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

Conditions
ConditionsYield
With sodium hydroxide; ascorbic acid at 20℃; for 2h; Darkness;
kaempferol 3-O-[(6-O-E-p-coumaroyl)-β-D-glucopyranosyl-(1→2)]-β-D-galactopyranoside-7-O-β-D-glucuropyranoside

kaempferol 3-O-[(6-O-E-p-coumaroyl)-β-D-glucopyranosyl-(1→2)]-β-D-galactopyranoside-7-O-β-D-glucuropyranoside

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

Conditions
ConditionsYield
With sodium hydroxide; ascorbic acid at 20℃; for 2h; Darkness;
juglanoside J

juglanoside J

A

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

B

(1S)-1,2,3,4-tetrahydro-8-hydroxy-4-oxonaphthalen-1-yl 6-O-[(3,4,5-trihydroxyphenyl)carbonyl]-β-D-glucopyranoside

(1S)-1,2,3,4-tetrahydro-8-hydroxy-4-oxonaphthalen-1-yl 6-O-[(3,4,5-trihydroxyphenyl)carbonyl]-β-D-glucopyranoside

Conditions
ConditionsYield
With sodium hydroxide at 20℃; for 6h;A 1.5 mg
B 2.8 mg
4-bromo-phenol
106-41-2

4-bromo-phenol

acrylic acid
79-10-7

acrylic acid

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

Conditions
ConditionsYield
With sodium carbonate; palladium dichloride In water at 100℃; for 2h;65%
With sodium carbonate; palladium dichloride at 100℃; for 2h;65%
4-hydroxy-benzaldehyde
123-08-0

4-hydroxy-benzaldehyde

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

Conditions
ConditionsYield
With hydrogenchloride; malonic acid; aniline In pyridine
1-O-(E)-caffeoyl-2-O-p-(E)-coumaroyl-β-D-glucopyranose

1-O-(E)-caffeoyl-2-O-p-(E)-coumaroyl-β-D-glucopyranose

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

Conditions
ConditionsYield
With hydrogenchloride; water at 90℃; for 3h; Sealed tube;
methyl 4-hydroxycinnamate
3943-97-3

methyl 4-hydroxycinnamate

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

Conditions
ConditionsYield
With lithium hydroxide monohydrate In tetrahydrofuran; methanol; water at 20℃; for 18h; Inert atmosphere; Schlenk technique; Glovebox;92%
peonidin 3-O-[2-O-(2-O-(trans-sinapoyl)-glucosyl)-6-O-(trans-p-coumaroyl)-glucoside]-5-O-[6-O-(malonyl)-glucoside]

peonidin 3-O-[2-O-(2-O-(trans-sinapoyl)-glucosyl)-6-O-(trans-p-coumaroyl)-glucoside]-5-O-[6-O-(malonyl)-glucoside]

A

D-Glucose
2280-44-6

D-Glucose

B

malonic acid
141-82-2

malonic acid

C

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

D

trans-3,5-dimethoxy-4-hydroxycinnamic acid
530-59-6

trans-3,5-dimethoxy-4-hydroxycinnamic acid

E

peonidin chloride
134-01-0

peonidin chloride

Conditions
ConditionsYield
With hydrogenchloride; water at 100℃; for 1h;
cyanidin 3-O-[2-O-(2-O-(trans-feruloyl)-glucosyl)-6-O-(trans-p-coumaroyl)-glucoside]-5-O-[6-O-(malonyl)-glucoside]

cyanidin 3-O-[2-O-(2-O-(trans-feruloyl)-glucosyl)-6-O-(trans-p-coumaroyl)-glucoside]-5-O-[6-O-(malonyl)-glucoside]

A

D-Glucose
2280-44-6

D-Glucose

B

(E)-3-(4-hydroxy-3-methoxyphenyl)acrylic acid
1135-24-6

(E)-3-(4-hydroxy-3-methoxyphenyl)acrylic acid

C

malonic acid
141-82-2

malonic acid

D

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

E

cyanidin chloride
528-58-5

cyanidin chloride

Conditions
ConditionsYield
With hydrogenchloride; water at 100℃; for 1h;
peonidin 3-O-[2-O-(2-O-(trans-feruloyl)-glucosyl)-6-O-(trans-p-coumaroyl)-glucoside]-5-O-[6-O-(malonyl)-glucoside]

peonidin 3-O-[2-O-(2-O-(trans-feruloyl)-glucosyl)-6-O-(trans-p-coumaroyl)-glucoside]-5-O-[6-O-(malonyl)-glucoside]

A

D-Glucose
2280-44-6

D-Glucose

B

(E)-3-(4-hydroxy-3-methoxyphenyl)acrylic acid
1135-24-6

(E)-3-(4-hydroxy-3-methoxyphenyl)acrylic acid

C

malonic acid
141-82-2

malonic acid

D

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

E

peonidin chloride
134-01-0

peonidin chloride

Conditions
ConditionsYield
With hydrogenchloride; water at 100℃; for 1h;
allivictoside C

allivictoside C

A

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

B

kaempferol 3,7,4'-tri-O-β-D-glucopyranoside

kaempferol 3,7,4'-tri-O-β-D-glucopyranoside

Conditions
ConditionsYield
With potassium hydroxide at 20℃; for 12h;
allivictoside E

allivictoside E

A

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

B

kaempferol 3,7,4'-tri-O-β-D-glucopyranoside

kaempferol 3,7,4'-tri-O-β-D-glucopyranoside

Conditions
ConditionsYield
With potassium hydroxide at 20℃; for 12h;
p-Coumaric Acid
7400-08-0

p-Coumaric Acid

4-hydroxyphenylpropionic acid
501-97-3

4-hydroxyphenylpropionic acid

Conditions
ConditionsYield
With hydrogen; platinum(IV) oxide In methanol under 760 Torr; Ambient temperature;100%
With hydrogen; palladium on activated charcoal In methanol100%
With hydrogen; palladium on activated charcoal In ethyl acetate at 20℃;99%
methanol
67-56-1

methanol

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

methyl 4-hydroxycinnamate
3943-97-3

methyl 4-hydroxycinnamate

Conditions
ConditionsYield
With sulfuric acid for 24h; Reflux;100%
With sulfuric acid for 7h; Heating;99%
With sulfuric acid for 24h; Reflux;99%
p-Coumaric Acid
7400-08-0

p-Coumaric Acid

acetic anhydride
108-24-7

acetic anhydride

4-acetoxycinnamic acid
27542-85-4

4-acetoxycinnamic acid

Conditions
ConditionsYield
With pyridine at 20℃;100%
With pyridine; dmap for 1.5h;97%
With pyridine at 25℃; for 24h;95%
p-Coumaric Acid
7400-08-0

p-Coumaric Acid

dimethyl sulfate
77-78-1

dimethyl sulfate

3-(4-methoxy-phenyl)acrylic acid methyl ester
3901-07-3

3-(4-methoxy-phenyl)acrylic acid methyl ester

Conditions
ConditionsYield
Stage #1: p-Coumaric Acid With potassium carbonate In acetone at 20℃; for 0.25h;
Stage #2: dimethyl sulfate In acetone at 20℃; for 8h; Heating / reflux;
99%
With potassium carbonate In acetone at 25℃; for 24h;92%
With potassium carbonate In acetone for 3h; Reflux;68%
1-hydroxy-pyrrolidine-2,5-dione
6066-82-6

1-hydroxy-pyrrolidine-2,5-dione

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

4-hydroxycinnamic acid N-hydroxysuccinimide ester
88492-43-7

4-hydroxycinnamic acid N-hydroxysuccinimide ester

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In tetrahydrofuran at 20℃;95%
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane for 18h; Ambient temperature;59%
With diisopropyl-carbodiimide In N,N-dimethyl-formamide at 20℃; for 2h;58%
p-Coumaric Acid
7400-08-0

p-Coumaric Acid

tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

(E)-3-(4'-((tert-butyldimethylsilyl)oxy)phenyl)acrylic acid
141222-28-8

(E)-3-(4'-((tert-butyldimethylsilyl)oxy)phenyl)acrylic acid

Conditions
ConditionsYield
With 1H-imidazole In N,N-dimethyl-formamide at 0 - 20℃; for 2h;100%
With 1H-imidazole In N,N-dimethyl-formamide at 20℃; for 3h;98%
With 1H-imidazole In N,N-dimethyl-formamide at 0 - 20℃; for 3h;98%
p-Coumaric Acid
7400-08-0

p-Coumaric Acid

trans-p-coumaric acid-4-O-sulfate

trans-p-coumaric acid-4-O-sulfate

Conditions
ConditionsYield
With sulfur trioxide trimethylamine complex; sodium hydrogencarbonate; sodium hydroxide In water at 20℃; for 96h;99%
With chlorosulfonic acid In pyridine at 20℃;63%
With D-glucose; aryl sulfotransferase SULT1A1 Rattus norvegicus; isopropyl β-D-thiogalactopyranoside for 96h; Reagent/catalyst; Enzymatic reaction;
p-Coumaric Acid
7400-08-0

p-Coumaric Acid

methyl 4-hydroxycinnamate
3943-97-3

methyl 4-hydroxycinnamate

Conditions
ConditionsYield
With sulfuric acid In methanol Heating / reflux;98%
With sulfuric acid In methanol; ethanol; water61%
With methanol; sulfuric acid
p-Coumaric Acid
7400-08-0

p-Coumaric Acid

4-Vinylphenol
2628-17-3

4-Vinylphenol

Conditions
ConditionsYield
With 4-methoxy-phenol In water; N,N-dimethyl-formamide at 150℃; for 4h; Solvent;97%
With 1-methyl-1H-imidazole; sodium hydrogencarbonate for 0.333333h; Heating; microwave irradiation;94%
With bis(1-oxyl-2,2,6,6-tetramethylpiperidin-4-yl)sebacate; potassium acetate In DMF (N,N-dimethyl-formamide) at 150℃; for 1.5h; Product distribution / selectivity;94%
4-benzylpyperidine
31252-42-3

4-benzylpyperidine

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

(E)-1-(4-benzylpiperidin-1-yl)-3-(4-hydroxyphenyl)prop-2-en-1-one

(E)-1-(4-benzylpiperidin-1-yl)-3-(4-hydroxyphenyl)prop-2-en-1-one

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃;56.5%
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃;47.7%
Stage #1: p-Coumaric Acid With 1,1'-carbonyldiimidazole In tetrahydrofuran at 20℃; for 0.5h; Condensation;
Stage #2: 4-benzylpyperidine In tetrahydrofuran at 20℃; Acylation;
19%
p-Coumaric Acid
7400-08-0

p-Coumaric Acid

hydroxytyrosol
10597-60-1

hydroxytyrosol

(2E)-3-(4-hydroxyphenyl)-2-propenoic acid 2-(3,4-dihydroxyphenyl)ethyl ester

(2E)-3-(4-hydroxyphenyl)-2-propenoic acid 2-(3,4-dihydroxyphenyl)ethyl ester

Conditions
ConditionsYield
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 20℃; for 48h;73%
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 0 - 20℃; for 48h; Mitsunobu Displacement; chemoselective reaction;66%
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 0 - 20℃; for 48h; Schlenk technique; Inert atmosphere;54%
With Escherichia coli strain B-CP1 at 30℃; for 24h; Microbiological reaction; Enzymatic reaction;
p-Coumaric Acid
7400-08-0

p-Coumaric Acid

benzyl bromide
100-39-0

benzyl bromide

(E)-4-benzyloxycinnamic acid
6272-45-3

(E)-4-benzyloxycinnamic acid

Conditions
ConditionsYield
With caesium carbonate In N,N-dimethyl-formamide92%
With potassium carbonate In acetone for 12h; Reflux;92%
With sodium hydroxide In ethanol82%
With potassium hydroxide In ethanol; water at 20℃; for 72h;41%
With sodium hydroxide
ethanol
64-17-5

ethanol

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

ethyl (E)-4-hydroxycinnamate
2979-06-8, 7361-92-4, 7362-39-2

ethyl (E)-4-hydroxycinnamate

Conditions
ConditionsYield
With sulfuric acid at 60℃;100%
With sulfuric acid at 65℃; for 18h;95%
With hydrogenchloride92%
p-Coumaric Acid
7400-08-0

p-Coumaric Acid

(E)-3-(4-hydroxyphenyl)acryloylhydrazide
90557-60-1

(E)-3-(4-hydroxyphenyl)acryloylhydrazide

Conditions
ConditionsYield
Stage #1: p-Coumaric Acid With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In acetonitrile at 25℃; for 2h;
Stage #2: With hydrazine hydrate In acetonitrile at 0 - 10℃;
79%
Stage #1: p-Coumaric Acid With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In acetonitrile at 20℃; for 2h;
Stage #2: With hydrazine hydrate In acetonitrile; cyclohexene at 0 - 10℃;
46%
Stage #1: p-Coumaric Acid With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In acetonitrile at 20℃; for 2h;
Stage #2: With hydrazine; cyclohexene In acetonitrile at 0 - 20℃; for 1.33333h;
36%
Multi-step reaction with 2 steps
1: 74 percent / Et3N / ethyl acetate / 6 h / Heating
2: 55 percent / N2H4 / CHCl3 / Heating
View Scheme
1,2,3,4-tetrahydroisoquinoline
91-21-4

1,2,3,4-tetrahydroisoquinoline

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

(E)-1-(3,4-dihydroisoquinolin-2(1H)-yl)-3-(4-hydroxyphenyl)prop-2-en-1-one

(E)-1-(3,4-dihydroisoquinolin-2(1H)-yl)-3-(4-hydroxyphenyl)prop-2-en-1-one

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃;76.7%
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃;62.7%
2-phenylethanol
60-12-8

2-phenylethanol

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

(2E)-3-(4-hydroxyphenyl)-2-propenoic acid 2-phenylethyl ester

(2E)-3-(4-hydroxyphenyl)-2-propenoic acid 2-phenylethyl ester

Conditions
ConditionsYield
With ytterbium(III) triflate In nitromethane at 120℃; for 1h;70.6%
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 20℃; for 48h;40%
With Escherichia coli strain B-CP1 at 30℃; for 24h; Microbiological reaction; Enzymatic reaction;
O-2-tetrahydro-2H-pyranhydroxylamine
6723-30-4

O-2-tetrahydro-2H-pyranhydroxylamine

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

(E)-3-(4-hydroxyphenyl)-N-((tetrahydro-2H-pyran-2-yl)oxy)acrylamide

(E)-3-(4-hydroxyphenyl)-N-((tetrahydro-2H-pyran-2-yl)oxy)acrylamide

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃;84%
propan-1-ol
71-23-8

propan-1-ol

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

(E)-propyl 3-(4-hydroxyphenyl)acrylate
94530-69-5

(E)-propyl 3-(4-hydroxyphenyl)acrylate

Conditions
ConditionsYield
With sulfuric acid for 3h;72%
With dmap; dicyclohexyl-carbodiimide at 50℃; for 24h;71%
With sulfuric acid Reflux;58.43%
16%
With sulfuric acid
p-Coumaric Acid
7400-08-0

p-Coumaric Acid

ethyl chloromethyl ether
3188-13-4

ethyl chloromethyl ether

ethoxymethyl 4-hydroxycinnamate
642471-45-2

ethoxymethyl 4-hydroxycinnamate

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃;84%
With triethylamine In dichloromethane at 0℃;84%
6-chloro-1-hexanol
2009-83-8

6-chloro-1-hexanol

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

4-(6-hydroxyhexyloxy)cinnamic acid
503000-67-7

4-(6-hydroxyhexyloxy)cinnamic acid

Conditions
ConditionsYield
Stage #1: p-Coumaric Acid With potassium hydroxide; potassium iodide In ethanol; water for 0.166667h;
Stage #2: 6-chloro-1-hexanol In ethanol; water at 30 - 40℃; Heating / reflux;
62%
With 1,3-dimethyl-2-imidazolidinone; potassium carbonate; potassium iodide at 130℃; for 17h;47%
Stage #1: p-Coumaric Acid With potassium iodide; potassium hydroxide In ethanol; water for 0.166667h; Reflux;
Stage #2: 6-chloro-1-hexanol In ethanol; water for 48h; Reflux;
Stage #3: With hydrogenchloride In ethanol; water
46.8%
p-Coumaric Acid
7400-08-0

p-Coumaric Acid

4-methoxy-aniline
104-94-9

4-methoxy-aniline

C16H15NO3

C16H15NO3

Conditions
ConditionsYield
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; triethylamine In dichloromethane; N,N-dimethyl-formamide for 6h;85%
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 23℃; for 24h;78.5%
p-Coumaric Acid
7400-08-0

p-Coumaric Acid

Carvacryl chloroacetate

Carvacryl chloroacetate

2-[2-methyl-5-(propan-2-yl)phenoxy]-2-oxoethyl (2E)-3-(4-hydroxyphenyl)prop-2-enoate

2-[2-methyl-5-(propan-2-yl)phenoxy]-2-oxoethyl (2E)-3-(4-hydroxyphenyl)prop-2-enoate

Conditions
ConditionsYield
With triethylamine; potassium iodide In N,N-dimethyl-formamide at 20℃; for 24h;80%
1-phenylmethylpiperazine
2759-28-6

1-phenylmethylpiperazine

p-Coumaric Acid
7400-08-0

p-Coumaric Acid

(E)-1-(4-benzylpiperazin-1-yl)-3-(4-hydroxyphenyl)prop-2-en-1-one

(E)-1-(4-benzylpiperazin-1-yl)-3-(4-hydroxyphenyl)prop-2-en-1-one

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃;63.7%
p-Coumaric Acid
7400-08-0

p-Coumaric Acid

hydroxymethylparthenolide
93930-15-5

hydroxymethylparthenolide

((1aR,7aS,10aS,10bS,E)-1a-methyl-8-methylene-9-oxo-1a,2,3,6,7,7a,8,9,10a,10b-decahydrooxireno[2′,3′:9,10]cyclodeca[1,2-b]furan-5-yl)methyl (E)-3-(4-hydroxyphenyl)acrylate

((1aR,7aS,10aS,10bS,E)-1a-methyl-8-methylene-9-oxo-1a,2,3,6,7,7a,8,9,10a,10b-decahydrooxireno[2′,3′:9,10]cyclodeca[1,2-b]furan-5-yl)methyl (E)-3-(4-hydroxyphenyl)acrylate

Conditions
ConditionsYield
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 20℃; Inert atmosphere;76%
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 20℃; for 4h; Inert atmosphere; Cooling with ice;69%
p-Coumaric Acid
7400-08-0

p-Coumaric Acid

hexan-1-ol
111-27-3

hexan-1-ol

trans-hexyl 3-(4-hydroxyphenyl)propenoate

trans-hexyl 3-(4-hydroxyphenyl)propenoate

Conditions
ConditionsYield
Stage #1: p-Coumaric Acid; hexan-1-ol In tetrahydrofuran at 0℃; for 0.5h; Mitsunobu Displacement;
Stage #2: With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 20℃; Mitsunobu Displacement;
36.88%
With di-isopropyl azodicarboxylate; triphenylphosphine In N,N-dimethyl-formamide for 12h; Ambient temperature;15 mg

7400-08-0Relevant articles and documents

Photoinduced Regioselective Olefination of Arenes at Proximal and Distal Sites

Ali, Wajid,Anjana, S. S.,Bhattacharya, Trisha,Chandrashekar, Hediyala B.,Goswami, Nupur,Guin, Srimanta,Maiti, Debabrata,Panda, Sanjib,Prakash, Gaurav,Saha, Argha,Sasmal, Sheuli,Sinha, Soumya Kumar

, p. 1929 - 1940 (2022/02/01)

The Fujiwara-Moritani reaction has had a profound contribution in the emergence of contemporary C-H activation protocols. Despite the applicability of the traditional approach in different fields, the associated reactivity and regioselectivity issues had

Reusable, magnetic Raney nickel based palladium catalysts for the Heck coupling in aqueous media

Bumagin, N. A.

, p. 2034 - 2040 (2021/11/05)

Hybrid materials based on Pd- and Cu-doped Raney nickel appeared to be highly efficient catalysts for the Heck reaction in aqueous media in the absence of organic cosolvents. The catalysts can be easily removed by an external magnet and reused without losing catalytic activity.

Iron-catalyzed domino decarboxylation-oxidation of α,β-unsaturated carboxylic acids enabled aldehyde C-H methylation

Gong, Pei-Xue,Xu, Fangning,Cheng, Lu,Gong, Xu,Zhang, Jie,Gu, Wei-Jin,Han, Wei

supporting information, p. 5905 - 5908 (2021/06/18)

A practical and general iron-catalyzed domino decarboxylation-oxidation of α,β-unsaturated carboxylic acids enabling aldehyde C-H methylation for the synthesis of methyl ketones has been developed. This mild, operationally simple method uses ambient air as the sole oxidant and tolerates sensitive functional groups for the late-stage functionalization of complex natural-product-derived and polyfunctionalized molecules.

Novel ester derivative of cinnamates with different long alkoxy chain: synthesis, mesomorphic properties, biological evaluation

Bhalodiya, Pradip C.,Patel, Hemant N.,Parmar, Tejasvi H.,Sangani, Chetan B.,Rajani, Dhanji P.

, p. 1 - 25 (2021/07/07)

A novel series of liquid crystals involving cinnamate-based mesogenic units interlinked between aromatic ester and alkyl bromide were designed and synthesized. All target molecules were confirmed by IR, 1H NMR, 13C NMR, ESI-MS, and elemental analysis. The mesomorphic behavior of novel synthesized materials (P1–P18), (V1–V18), and (M1–M18) was investigated through a polarizing optical microscope, differential scanning calorimetry, and thermogravimetric analysis (TGA) analysis. The lower carbon chain substituted member showed nematic phase while compound possess higher carbon chain exhibited only SmC phase. Thermal stability is determined by TGA analysis. All the cinnamate derivatives were screened for their anti-microbial, anti-malarial, and anti-tuberculosis potency. Among them, most of the derivatives exhibited outstanding anti-bacterial and anti-tuberculosis activity. Some derivatives also exhibited potent anti-fungal activity.

Acylated pelargonidin and cyanidin 3-sambubiosides from the flowers of Aeschynanthus species and cultivars

Iwashina, Tsukasa,Mizuno, Takayuki,Rahayu, Sri,Sugahara, Kohtaro,Tsutsumi, Chie,Widyatmoko, Didik

, (2021/10/01)

Thirteen anthocyanins were isolated from the flowers of two Aeschynanthus species, A. fulgens and A. pulcher, and six cultivars, ‘Mahligai’, ‘Mona Lisa’, ‘SoeKa’, ‘Redona’, ‘Freshya’ and ‘Bravera’, and identified as pelargonidin and cyanidin 3-O-sambubiosides and their malonates, succinates, p-coumarates and caffeates, and pelargonidin 3-O-glucoside by acid hydrolysis, HR-MS and NMR. Of their anthocyanins, pelargonidin 3-O-[xylosyl-(1 → 2)-(6''-malonylglucoside)] (2), pelargonidin 3-O-[xylosyl-(1 → 2)-(6''-succinylglucoside)] (3), pelargonidin 3-O-[xylosyl-(1 → 2)-(6''-E-p-coumaroylglucoside)] (4), pelargonidin 3-O-[xylosyl-(1 → 2)-(6''-Z-p-coumaroylglucoside)] (5), pelargonidin 3-O-[xylosyl-(1 → 2)-(6''-E-caffeoylglucoside)] (6) and cyanidin 3-O-[xylosyl-(1 → 2)-(6''-succinylglucoside)] (9) were reported in nature for the first time.

Design, synthesis, and evaluation of different scaffold derivatives against NS2B-NS3 protease of dengue virus

Ganji, Lata R.,Gandhi, Lekha,Musturi, Venkataramana,Kanyalkar, Meena A.

, p. 285 - 301 (2020/11/19)

The number of deaths or critical health issues is a threat in the infection caused by Dengue virus, which complicates the situation, as only symptomatic treatment is the current solution. In this regard we have targeted the dengue protease NS2B-NS3 that is responsible for the replication. The series was designed with the help of molecular modeling approach using docking protocols. The series comprised of different scaffolds viz. cinnamic acid analogs (CA1–CA11), chalcone (C1–C10) and their molecular hybrids (Lik1–Lik10), analogs of benzimidazole (BZ1-BZ5), mercaptobenzimidazole (BS1-BS4), and phenylsulfanylmethylbenzimidazole (PS1-PS4). Virtual screening of various natural phytoconstituents was employed to determine the interactions of designed analogs with the residues of catalytic triad in the active site of NS2B-NS3. We have further synthesized the selected leads. The synthesized analogs were evaluated for the cytotoxicity and NS2B-NS3 protease inhibition activity and compared with known anti-dengue natural phytoconstituent quercetin as the standard. CA2, BZ1, and BS2 were found to be more potent and efficacious than the standard quercetin as evident from the protease inhibition assay.

Dual Nickel/Ruthenium Strategy for Photoinduced Decarboxylative Cross-Coupling of α,β-Unsaturated Carboxylic Acids with Cycloketone Oxime Esters

Gao, Ang,Jiang, Run-Chuang,Liu, Chuang-Chuang,Liu, Qi-Le,Lu, Xiao-Yu,Xia, Ze-Jie

supporting information, p. 8829 - 8842 (2021/06/30)

Herein, a dual nickel/ruthenium strategy is developed for photoinduced decarboxylative cross-coupling between α,β-unsaturated carboxylic acids and cycloketone oxime esters. The reaction mechanism is distinct from previous photoinduced decarboxylation of α,β-unsaturated carboxylic acids. This reaction might proceed through a nickelacyclopropane intermediate. The C(sp2)-C(sp3) bond constructed by the aforementioned reaction provides an efficient approach to obtaining various cyanoalkyl alkenes, which are synthetically valuable organic skeletons in organic and medicinal chemistry, under mild reaction conditions. The protocol tolerates many critical functional groups and provides a route for the modification of complex organic molecules.

Ballodiolic acid a and b: Two new ros, (? oh), (onoo? ) scavenging and potent antimicrobial constituents isolated from ballota pseudodictamnus (l.) benth.

Ahmad, Ijaz,Ahmad, Nisar,Alobaid, Abdulrahman,Amin, Syed Badar,Bari, Ahmed,Fozia,Mahmood, Hafiz Majid,Shaheen, Asmat,Sohaib, Muhammad,Ullah, Riaz

, (2021/04/07)

Bioassays guided phytochemical investigations on the ethyl acetate-soluble fraction of the root material of Ballota pseudodictamnus (L.) Benth. led to the isolation of two new compounds, ballodiolic acid A (1) and ballodiolic acid B (2), along with three known compounds ballodiolic acid (3), ballotenic acid (4), and β-amyrin (5), which were also isolated for the first time from this species by using multiple chromatographic techniques. The structures of the compounds (1–5) were determined by modern spectroscopic analysis including 1D and 2D NMR techniques and chemical studies. In three separate experiments, the isolated compounds (1–5) demonstrated potent antioxidant scavenging activity, with IC50 values ranging from 07.22–34.10 μM in the hydroxyl radical (? OH) inhibitory activity test, 58.10–148.55 μM in the total ROS (reactive oxygen species) inhibitory activity test, and 6.23–69.01 μM in the peroxynitrite (ONOO? ) scavenging activity test. With IC50 values of (07.22 ± 0.03, 58.10 ± 0.07, 6.23 ± 0.04 μM) for? OH, total ROS, and scavenge ONOO?, respectively, ballodiolic acid B (2) showed the highest scavenging ability. Antibacterial and antifungal behaviors were also exposed to the pure compounds 1–5. In contrast to compounds 4 and 5, compounds 1–3 were active against all bacterial strains studied, with a good zone of inhibition proving these as a potent antibacterial agent. Similarly, compared to compounds 3–5, compounds 1 and 2 with a 47 percent and 45 percent respective inhibition zone were found to be more active against tested fungal strains.

Amino Group Functionalized Hf-Based Metal-Organic Framework for Knoevenagel-Doebner Condensation

Das, Aniruddha,Anbu, Nagaraj,Gogoi, Chiranjib,Dhakshinamoorthy, Amarajothi,Biswas, Shyam

, p. 3396 - 3403 (2021/08/20)

A Hf(IV) metal-organic framework (MOF) with di-amino functionalized linker was obtained as a crystalline solid with UiO-67 topology under solvothermal reaction conditions. The guest free form of Hf(IV) MOF (1′) was efficiently employed as a heterogeneous catalyst to synthesize cinnamic acid derivatives via Knoevenagel-Doebner reaction for the first time. The catalyst (1′) was efficiently active to directly achieve cinnamic acid from benzaldehyde and malonic acid. The solid retained its activity up to 6th cycle with no decay in its activity. The noticeable advantages of the catalyst are its milder reaction conditions, high yield, high stability, recyclable nature towards catalysis and wide substrate scope as well as shape-selective behaviour. The possible mechanism of the reaction was also studied thoroughly with suitable control experiments.

Identification of novel functionalized carbohydrazonamides designed as chagas disease drug candidates

Do Nascimento, Mayara S. S.,Camara, Vitória R. F.,da Costa, Juliana S.,Barbosa, Juliana M. C.,Lins, Alessandra S. M.,Salom?o, Kelly,de Castro, Solange L.,Carvalho, Samir A.,da Silva, Edson F.,Fraga, Carlos A. M.

, p. 774 - 783 (2020/08/19)

Background: Although several research efforts have been made worldwide to discover novel drug candidates for the treatment of Chagas disease, the nitroimidazole drug benznidazol remains the only therapeutic alternative in the control of this disease. However, this drug presents reduced efficacy in the chronic form of the disease and limited safety after long periods of admini-stration, making it necessary to search for new, more potent and safe prototypes. Objective: We described herein the synthesis and the trypanocidalaction of new functionalized carbohydrazonamides (2-10) against trypomastigote forms of Trypanosoma cruzi. Methods: These compounds were designed through the application of molecular hybridization concept between two potent anti-T. cruzi prototypes, the nitroimidazole derivative megazol (1) and the cinnamyl N-acylhydrazone derivative (14) which have been shown to be twice as potent in vitro as benznidazole. Results: The most active compounds were the (Z)-N'-((E)-3-(4-nitrophenyl)-acryloyl)-1-methyl-5-nitro-1H-imidazol-2-carbohydrazonamide (6) (IC50 =9.50 μM) and the (Z)-N'-((E)-3-(4-hydroxyphe-nyl)-acryloyl)-1-methyl-5-nitro-1H-imidazol-2-carbohydrazonamide (8) (IC50 =12.85 μM), which were almost equipotent to benznidazole (IC50 =10.26 μM) used as standard drug. The removal of the amine group attached to the imine subunit in the corresponding N-acylhydrazone derivatives (11-13) resulted in less potent or inactive compounds. The para-hydroxyphenyl derivative (8) presented also a good selectivity index (SI = 32.94) when tested against mammalian cells from Swiss mice. Conclusion: The promising trypanocidal profile of new carbohydrazonamide derivatives (6) and (8) was characterized. These compounds have proved to be a good starting point for the design of more effective trypanocidal drug candidates.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 7400-08-0